Indefinite Delivery Contract SPE2DU25D5133

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D2105 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines,...
The Indefinite Delivery Contract (IDC) SPE2DU25D5136 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999.00 single-award IDC has an ultimate completion date of December 31, 2036 and provides a mechanism for the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
The Indefinite Delivery Contract (IDC) SPE2DU25D3206 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $4,999,999 and runs through December 31, 2036. This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation, which aims to establish multiple prime vendor contracts...
The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, valued at $4,999,999, has an ultimate completion date of December 31, 2036 and was awarded on June 3, 2025. The IDC is part of the Pharmaceutical Prime Vendor Global Program Generation V...
The Indefinite Delivery Contract (IDC) SPE2DU25D2017 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999.00 single-award contract, which runs through December 31, 2036, is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The contract aims to establish pharmaceutical prime vendor agreements to provide...
The Indefinite Delivery Contract (IDC) SPE2DU25D1027, awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $4,999,999 IDC has a period of performance through December 31, 2036 and serves as a primary vehicle for the DLA to procure specialty medications, brand-name and generic drugs, vaccines, syringes,...
The Indefinite Delivery Contract (IDC) SPE2DU25D5117 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $999,999,999 and runs through December 2036, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, valued at $999,999,999, runs through December 2036 and covers critical medical commodities including specialty medications,...
The Indefinite Delivery Contract (IDC) SPE2DR25D7062 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,999,999,999 IDC, running through December 2036, is a prime vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The underlying solicitation, known as the...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. The $4,999,999 contract has a period of performance through December 31, 2036 and is designated as a single award with no set-asides used. The IDC is part of the DLA's...

The Indefinite Delivery Contract (IDC) SPE2DU25D5133 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999,999, has an ultimate completion date of December 31, 2036 and covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple Prime Vendor Contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, US Coast Guard, and US Naval Fleet. The contract encompasses critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The DLA intends to make multiple regional awards under this fully competitive, Lowest Price Technically Acceptable (LPTA) procurement, with the goal of ensuring diverse supply sources and enhancing the DoD's resiliency in accessing vital pharmaceuticals during contingencies or natural disasters.

Generated 6/6/25, 10:10 AM